Global Medical Partners
Leveraging the "National 9 Articles" special policies of Hainan Boao Lecheng Pilot Zone, we connect you to Japan's largest private medical group, China's #1 hematology brand, the world's largest stem cell bank, and other world-class medical resources.
Boao Super Hospital
Boao Lecheng, Hainan · China
A Grade-III general hospital in China's only "medical special zone." Led by Academician Li Lanjuan with 10+ academician teams. Under special State Council policies, it can use international cutting-edge drugs and devices years before mainland approval. Completed 50+ "first in China" procedures in ophthalmology, cardiology, ENT, oncology, and stem cell therapy.
Xinwakai Medical Corporation
Tokyo · Japan
Japan's largest private medical conglomerate, operating Shinwa Medical Resort (Yachiyo & Kashiwanoha), Koto Medical Tower (7 floors, 4000m²), and multiple university-affiliated hospitals. Through JIMC (Japan International Medical Center), we offer premium Japanese health screening, anti-aging, critical care, and regenerative medicine services.
Lu Daopei Medical Group
Beijing / Hebei / Shanghai · China
Founded by Academician Lu Daopei, the "Father of Asian Bone Marrow Transplantation." China's largest hematology medical service provider with 4 hospitals. Annual allogeneic HSCT volume ranks among the highest globally, with advanced CAR-T immunotherapy programs.
Ruijin Hospital Hainan
Boao Lecheng, Hainan · China
Affiliated with Shanghai Jiao Tong University School of Medicine. Leads the most biomedical technology projects in Lecheng, including airway basal stem cell therapy for COPD/bronchiectasis/ILD, RPE65 gene therapy for inherited retinal dystrophy, and iPSC-derived neural progenitor cells for ALS.
West China Lecheng Hospital
Boao Lecheng, Hainan · China
West China Hospital (Sichuan University) extension in Lecheng. Offers hemophilia A gene therapy (AAV vector, ¥680K/dose), heart failure MSC therapy, liver cirrhosis MSC therapy, melanoma DC vaccine, and endothelial progenitor cell therapy for critical limb ischemia.
Hubei Stem Cell Bank
Wuhan, Hubei · China
Founded by Academician Lu Daopei and approved by Hubei Provincial S&T Department. The world's largest cell preservation bank, built to AABB standards. Using -196°C liquid nitrogen cryopreservation, cells maintain 95%+ viability after 35 years. Offers immune cell and MSC (umbilical cord, dental pulp, adipose) storage.
Boao Lecheng International Medical Tourism Pilot Zone
China's only "medical special zone," established by the State Council in 2013. Under four franchise policies — Franchise Medical Care, Franchise Research, Franchise Operation, and Franchise International Medical Tourism — Lecheng can legally use international cutting-edge drugs, devices, and biomedical technologies before they are approved elsewhere in China, bypassing the typical 5-10 year registration wait.
Franchise Medical Care
Use overseas-approved drugs, devices & technologies not yet registered in China
Franchise Research
Real-world data studies to accelerate domestic regulatory approval
Franchise Operation
Wholly foreign-owned medical institutions & fast-tracked international expert approval
Franchise Intl. Medical Tourism
86-country visa-free entry; 560K+ medical tourism visits in 2026
29 approved biomedical technology projects covering stem cell therapy, immunotherapy, and gene therapy — all with transparent public pricing (¥36K-680K), serving 400+ patients.
Key projects: Knee osteoarthritis MSC (¥36K/session), COPD airway stem cell (¥150K/session), Hemophilia A gene therapy (¥680K/dose), Autologous NK anti-cancer (¥49.8K/session), iPSC for ALS, DC vaccine for tumors.
Need Help Finding the Right Hospital and Specialist?
Our medical advisor team will match you with the most suitable partner hospital and treatment plan based on your health needs — completely free of charge.
Book a Consultation